For the treatment of the following infections caused by susceptible microorganisms: Skin and skin structure infections; Intra-abdominal infections (e.g., complicated appendicitis, peritonitis); Bacterial meningitis (Note: There is limited adult efficacy data for meropenem in the treatment of bacterial meningitis. Support for meningitis indication in adults is largely provided by pediatric data.); Lower respiratory tract infections (e.g., community-acquired pneumonia, healthcare-associated pneumonia), including patients with cystic fibrosis; Complicated urinary tract infections; Gynecological infections (e.g., endometritis, pelvic inflammatory disease, postpartum infections); Septicemia; Empiric treatment of patients with febrile neutropenia, used as monotherapy or in combination with other antimicrobial drugs.